Behind the Study: Evaluations in TRAMP Prostate Cancer Model

Oncotarget | September 20, 2021
Dr. Yves Chabu from the University of Missouri describes a research paper he co-authored in 2020 that was published by Oncotarget, entitled, “Evaluations of CRC2631 toxicity, tumor colonization, and genetic stability in the TRAMP prostate cancer model.” continue reading »

Oncotarget Testimonial: Dr. Yves Chabu

Oncotarget | September 17, 2021
Dr. Yves Chabu discusses his experience publishing the paper, “Evaluations of CRC2631 toxicity, tumor colonization, and genetic stability in the TRAMP prostate cancer model,” with Oncotarget. continue reading »

New Study: Nanoparticles Target Acute Myeloid Leukemia

Oncotarget | September 15, 2021
Researchers developed a nanoparticle-based T cell engager (nanoTCE) technology believed to be capable of targeting any immune cell and cancer of interest. NanoTCE efficacy was examined in acute myeloid leukemia. continue reading »

Behind the Study: Evaluations in TRAMP Prostate Cancer Model

Spotlight | September 20, 2021
Dr. Yves Chabu from the University of Missouri describes a research paper he co-authored in 2020 that was published by Oncotarget, entitled, “Evaluations of CRC2631 toxicity, tumor colonization, and genetic stability in the TRAMP prostate cancer model.” continue reading »

Behind the Study: EMT, Endothelial Cells & Tumor Growth

Spotlight | September 13, 2021
Dr. Tapasree Roy Sarkar describes a research paper she co-authored, entitled, "Carcinoma cells that have undergone an epithelial-mesenchymal transition differentiate into endothelial cells and contribute to tumor growth." continue reading »

Behind the Study: Second Interventions in Aging Conference

Spotlight | August 30, 2021
Following the Second Interventions in Aging Conference, meeting organizers Dr. Brian Kennedy and Dr. Linda Partridge discuss their overview of the meeting proceeding. continue reading »

Aging Testimonial: Dr. Dale Bredesen

Aging | September 17, 2021
Dr. Dale Bredesen discusses his experience publishing the paper, “Alzheimer’s disease as a systems network disorder: chronic stress/dyshomeostasis, innate immunity, and genetics,” with Aging (Aging-US). continue reading »

Trending With Impact: Metabolomics Discerns Sarcopenia From Frailty

Aging | September 16, 2021
Sarcopenic patients share clinical features with frailty, but just how similar are they? Researchers used metabolomic analysis to assess the metabolic profiles of sarcopenia in relation to frailty. continue reading »

​​Immunosenescence and the Aging Immune System

Aging | September 7, 2021
Literature on the interaction between cellular senescence and the immune system is reviewed, with a focus on cellular senescence in lymphoid organs. continue reading »

Aging Testimonial: Dr. Dale Bredesen

Testimonials | September 17, 2021
Dr. Dale Bredesen discusses his experience publishing the paper, “Alzheimer’s disease as a systems network disorder: chronic stress/dyshomeostasis, innate immunity, and genetics,” with Aging (Aging-US). continue reading »

Oncotarget Testimonial: Dr. Yves Chabu

Testimonials | September 17, 2021
Dr. Yves Chabu discusses his experience publishing the paper, “Evaluations of CRC2631 toxicity, tumor colonization, and genetic stability in the TRAMP prostate cancer model,” with Oncotarget. continue reading »

Oncotarget Testimonial: Dr. Tapasree Roy Sarkar

Testimonials | September 8, 2021
Dr. Tapasree Roy Sarkar discusses her experience publishing the paper, “Carcinoma cells that have undergone an epithelial-mesenchymal transition differentiate into endothelial cells and contribute to tumor growth,” with Oncotarget. continue reading »

Press Release: Aging’s Latest Impact Factor

News | August 20, 2021
In June 2021, Web of Science (Clarivate Analytics) released their 2020 JCR Impact Factor. Aging is pleased to report that our 2020 impact factor is 5.682. continue reading »

Captain of Team Open Access Rides Again for Cancer Research

News | August 18, 2021
Sponsored by Impact Journals, Team Open Access is once again captained by Sergei Kurenov who explains his motivation to participate in the Ride for Roswell. continue reading »

The Ride for Roswell: Rolling Around The Track August 7

News | July 28, 2021
Impact Journals is sponsoring Team Open Access in the annual cycling event to end cancer: The Ride for Roswell. This fundraiser is hosted by Roswell Park Comprehensive Cancer Center in Buffalo, New York. continue reading »